CN102695427B - 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物 - Google Patents

包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物 Download PDF

Info

Publication number
CN102695427B
CN102695427B CN201080036917.7A CN201080036917A CN102695427B CN 102695427 B CN102695427 B CN 102695427B CN 201080036917 A CN201080036917 A CN 201080036917A CN 102695427 B CN102695427 B CN 102695427B
Authority
CN
China
Prior art keywords
purposes
composition
allergic
food
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080036917.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN102695427A (zh
Inventor
S·霍尔沃特
A·梅赛尼尔
A·齐歇尔
A·辛格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Societe dAssistance Technique pour Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42778049&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102695427(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe dAssistance Technique pour Produits Nestle SA filed Critical Societe dAssistance Technique pour Produits Nestle SA
Publication of CN102695427A publication Critical patent/CN102695427A/zh
Application granted granted Critical
Publication of CN102695427B publication Critical patent/CN102695427B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201080036917.7A 2009-08-18 2010-08-13 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物 Expired - Fee Related CN102695427B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09168053.8 2009-08-18
EP09168053 2009-08-18
EP09170599 2009-09-17
EP09170599.6 2009-09-17
PCT/EP2010/061803 WO2011020780A1 (en) 2009-08-18 2010-08-13 A nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children.

Publications (2)

Publication Number Publication Date
CN102695427A CN102695427A (zh) 2012-09-26
CN102695427B true CN102695427B (zh) 2016-04-13

Family

ID=42778049

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080036917.7A Expired - Fee Related CN102695427B (zh) 2009-08-18 2010-08-13 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物

Country Status (16)

Country Link
US (1) US9049881B2 (enExample)
EP (1) EP2467031B1 (enExample)
CN (1) CN102695427B (enExample)
AU (1) AU2010285068B2 (enExample)
BR (1) BR112012003706A2 (enExample)
CA (1) CA2770099A1 (enExample)
CL (1) CL2012000417A1 (enExample)
ES (1) ES2518490T3 (enExample)
IN (1) IN2012DN00878A (enExample)
MX (1) MX2012002039A (enExample)
PL (1) PL2467031T3 (enExample)
PT (1) PT2467031E (enExample)
SG (1) SG178139A1 (enExample)
TW (1) TW201117733A (enExample)
WO (1) WO2011020780A1 (enExample)
ZA (1) ZA201202009B (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9457077B2 (en) 2009-11-18 2016-10-04 Katherine Rose Kovarik Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
US9408880B2 (en) 2013-12-20 2016-08-09 Katherine Rose Kovarik Method and system for prevention and treatment of allergic and inflammatory diseases
US9585920B2 (en) 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
BR112014000322A2 (pt) * 2011-07-12 2017-01-10 Nestec Sa "probióticos, e seus usos"
WO2013052101A1 (en) * 2011-10-03 2013-04-11 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
EP2617296A1 (en) 2012-01-19 2013-07-24 Nestec S.A. A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
DK3628161T3 (da) 2012-11-23 2023-05-30 Seres Therapeutics Inc Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
CN104936464A (zh) 2013-01-21 2015-09-23 苏黎世联邦理工学院 包含产丙酸活细菌的婴儿食物组合物
AU2014212004B2 (en) 2013-02-04 2018-09-20 Société des Produits Nestlé S.A. Compositions for treating or preventing or reducing the severity of clostridium difficile related diseases
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
EP2967077A4 (en) 2013-03-15 2016-09-14 Seres Therapeutics Inc NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
KR102611070B1 (ko) 2013-11-25 2023-12-07 세레스 테라퓨틱스, 인코포레이티드 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US12318377B2 (en) 2013-12-20 2025-06-03 Seed Health, Inc. Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
CA2964971C (en) 2014-10-28 2023-04-11 Medlab Ip Pty Ltd Treatment for depression and depressive disorders
CA2977127A1 (en) * 2015-02-20 2016-08-25 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
EP3654778A1 (en) 2017-07-18 2020-05-27 Before Brands, Inc. Methods for making mixed allergen compositions
MX2020001774A (es) 2017-08-14 2020-09-09 Seres Therapeutics Inc Composiciones y métodos para tratar enfermedad colestásica.
BR112020008552A2 (pt) 2017-10-30 2020-12-29 Seres Therapeutics, Inc. métodos e composições para tratamento de resistência a antibiótico
WO2019178325A1 (en) 2018-03-14 2019-09-19 Emory University Lactococcus bacteria and uses thereof
CN109212129A (zh) * 2018-06-30 2019-01-15 湖北海纳天鹰科技发展有限公司 一种规避空气中过敏原的目的地选择方法和装置
CN113507844A (zh) 2019-01-23 2021-10-15 前品牌股份有限公司 制备混合型过敏原组合物的方法
AU2022224953A1 (en) * 2021-02-23 2023-07-20 Société des Produits Nestlé S.A. Composition and kit for alleviating symptoms of respiratory allergy in toddlers

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077101A (en) * 1980-05-12 1981-12-16 Kyokuto Fatty Acid Corp Antiallergic composition containing streptococci
WO1997000078A1 (en) * 1995-06-14 1997-01-03 Valio Oy Methods of preventing or treating allergies
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
EP1538198A2 (en) * 2003-11-28 2005-06-08 National Institute of Agrobiological Sciences Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
CN101328468A (zh) * 2007-06-21 2008-12-24 东宇生物科技股份有限公司 抗过敏的乳酸菌
WO2009007515A1 (en) * 2007-07-12 2009-01-15 Valio Ltd Lactic acid bacteria having pro-inflammatory characteristics
WO2009082214A1 (en) * 2007-12-21 2009-07-02 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5946488B2 (ja) * 1978-08-07 1984-11-13 極東脂肪酸株式会社 アレルギ−反応抑制剤
CN1149969A (zh) 1996-09-18 1997-05-21 任圣启 类母乳系列保健产品的制造技术
ATE206873T1 (de) * 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
JP4308481B2 (ja) * 2002-06-18 2009-08-05 独立行政法人農業・食品産業技術総合研究機構 抗アレルギー剤
US20060263344A1 (en) * 2003-04-02 2006-11-23 Mitchell Skop Novel probiotic compositions and methods of using the same
JP2006028050A (ja) * 2004-07-14 2006-02-02 Combi Corp 皮膚アレルギー抑制組成物
WO2006097949A1 (en) 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
US20080003329A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
NL1032840C2 (nl) 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
DK1964570T3 (da) * 2007-03-02 2012-12-17 Protectimmun Gmbh Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme
CA2684001A1 (en) * 2007-04-27 2008-11-06 Naked Juice Co. Of Glendora, Inc. Fruit juice beverages with probiotic bacteria
JP2009060800A (ja) * 2007-09-04 2009-03-26 Tsujido Kagaku Kk 食品組成物

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077101A (en) * 1980-05-12 1981-12-16 Kyokuto Fatty Acid Corp Antiallergic composition containing streptococci
WO1997000078A1 (en) * 1995-06-14 1997-01-03 Valio Oy Methods of preventing or treating allergies
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
EP1538198A2 (en) * 2003-11-28 2005-06-08 National Institute of Agrobiological Sciences Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
CN101328468A (zh) * 2007-06-21 2008-12-24 东宇生物科技股份有限公司 抗过敏的乳酸菌
WO2009007515A1 (en) * 2007-07-12 2009-01-15 Valio Ltd Lactic acid bacteria having pro-inflammatory characteristics
WO2009082214A1 (en) * 2007-12-21 2009-07-02 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes;H.S.Gill,et al;《JOURNAL OF CLINICAL IMMUNOLOGY》;20011231;第21卷(第4期);第264-271页 *
Dietary unripe apple polyphenol inhibits the development of food allergies in murine models;Hiroshi Akiyama, et al;《FEBS letters》;20050726;第579卷;第4485-4491页 *
Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization;Christophe P.Frossard, et al;《JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY》;20070306;第119卷(第4期);第952-959页 *

Also Published As

Publication number Publication date
IN2012DN00878A (enExample) 2015-05-22
RU2012110168A (ru) 2013-09-27
EP2467031A1 (en) 2012-06-27
TW201117733A (en) 2011-06-01
CA2770099A1 (en) 2011-02-24
AU2010285068B2 (en) 2015-05-28
CN102695427A (zh) 2012-09-26
CL2012000417A1 (es) 2012-09-28
EP2467031B1 (en) 2014-09-24
SG178139A1 (en) 2012-03-29
WO2011020780A1 (en) 2011-02-24
US9049881B2 (en) 2015-06-09
BR112012003706A2 (pt) 2015-09-01
AU2010285068A1 (en) 2012-03-29
PL2467031T3 (pl) 2015-03-31
PT2467031E (pt) 2014-10-30
US20120148629A1 (en) 2012-06-14
MX2012002039A (es) 2012-04-11
ZA201202009B (en) 2014-08-27
ES2518490T3 (es) 2014-11-05

Similar Documents

Publication Publication Date Title
CN102695427B (zh) 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物
US9439449B2 (en) Nutritional composition comprising Bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
JP6105629B2 (ja) 特定のラクトバチルス・ヘルベティカス株を含み、食物及び／又は呼吸器アレルギー症状を軽減する組成物
JP7407195B2 (ja) アレルギー性疾患の治療のためのプロバイオティクスの組み合わせ
CN105765058A (zh) 经热处理的乳酸双歧杆菌ncc2818制剂减轻变态反应的表现
RU2575072C2 (ru) Пищевая композиция, содержащая штаммы lactococcus и уменьшающая сиптомы аллергии, в частности у младенцев и детей
CN119924445A (zh) 预防或缓解婴幼儿食物过敏的杂粮谷物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160413

Termination date: 20170813